Showing results (871-880 of 966) with videos related to

Sort By:
Pageof 97
G3 (Bethesda, Md.)|September 5, 2015
Convergent Loss of Awn in Two Cultivated Rice Species Oryza sativa and Oryza glaberrima Is Caused by Mutations in Different LociTomoyuki Furuta, Norio Komeda, Kenji Asano, et al.
The Journal of Biological Chemistry|September 5, 2001
The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistanceT Yamauchi, J Kamon, H Waki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 25, 2024
[A Case of Pathological Complete Response after Nivolumab Therapy in Unresectable Advanced Gastric Cancer]Rei Ogura, Kazuhiro Migita, Ayumi Nishioka, et al.
Experimental Cell Research|February 12, 2022
Resistance to mutant KRAS<sup>V12</sup>-induced senescence in an hTERT/Cdk4-immortalized normal human bronchial epithelial cell lineNao Muraki, Mizuki Yamada, Hinako Doki, et al.
Oncology|December 20, 2017
Computer-Aided Diagnosis Based on Convolutional Neural Network System for Colorectal Polyp Classification: Preliminary ExperienceYoriaki Komeda, Hisashi Handa, Tomohiro Watanabe, et al.
Hepatology (Baltimore, Md.)|April 26, 2012
Retinoids ameliorate insulin resistance in a leptin-dependent manner in miceHiroyuki Tsuchiya, Yoshito Ikeda, Yu Ebata, et al.
Annals of Gastroenterology|June 29, 2017
Experimental gastric endoscopic submucosal dissection: training in a porcine modelPanagiotis Kasapidis, Stefanos Bassioukas, Georgios Mavrogenis, et al.
Hepato-Gastroenterology|February 26, 2015
Higher complication rate in hepatocellular carcinoma patients undergoing prophylactic cholecystectomy with curative hepatic resectionMasaki Kaibori, Shoji Kubo, Hiroaki Nagano, et al.
Digestive Diseases (Basel, Switzerland)|October 18, 2016
Clinical Factors Predicting the Effect of Tolvaptan for Refractory Ascites in Patients with Decompensated Liver CirrhosisHirokazu Chishina, Satoru Hagiwara, Naoshi Nishida, et al.
Internal Medicine (Tokyo, Japan)|April 19, 2019
Usefulness of Ustekinumab for Treating a Case of Myelodysplastic Syndrome-associated Inflammatory Bowel DiseaseMasashi Kono, Toshiharu Sakurai, Kazuki Okamoto, et al.
Pageof 97